---
$id: https://graph.org.ai/products/commodity/51131748
$type: Product
source: UNSPSC
code: "51131748"
title: "Ifetroban sodium"
class: "51131700"
classTitle: "Thrombolytic drugs and platelet aggregation inhibitors"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ifetroban sodium

**UNSPSC Code**: 51131748
**Class**: [Thrombolytic drugs and platelet aggregation inhibitors](Thrombolytic drugs and platelet aggregation inhibitors.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiplatelet agent C25H31N2O5.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 48IJA0E92C, chemically known as benzenepropanoic acid, 2-((3-(4-((pentylamino)carbonyl)-2-oxazolyl)-7-oxabicyclo(2.2.1)hept-2-yl)methyl)-, monosodium salt, (1s-(exo,exo))-, but more generally known as ifetroban sodium, which bears US NIH Compound Identifier 23663994. Most nations, for tariff and trade purposes, schedule ifetroban sodium under HS 29349990 and SITC 51579. As of Q4 2014, IFETROBAN SODIUM remains US FDA's Preferred Term for this commodity. Ifetroban sodium bears US NLM identifiers UMLS ID C2825686 and NCI Concept Code C81569. SMILES: CCCCCNC(=O)C1COC(N1)[C@@H]2[C@H]3CC[C@@H]([C@@H]2CC4CCCCC4CCC(=O)[O-])O3.[NA+].

